Quick Answer
Rapport Therapeutics, Inc. reported Total Assets of $512.43 million for the year ending 2025.
- Rapport Therapeutics, Inc. showed an increase of +62.7% in Total Assets from 2024 to 2025.
- This data is from Rapport Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2024: $346.10 million | Q3 2024: $331.14 million | Q1 2025: $302.05 million | Q2 2025: $285.50 million | Q3 2025: $535.32 million.
- Over the full 3 years of available data (2023 to 2025), Rapport Therapeutics, Inc.'s Total Assets has grown by 229.7%.
- Historical annual values: Fiscal year 2025: $512.43 million | Fiscal year 2024: $314.93 million | Fiscal year 2023: $155.42 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: